Konekte ak nou

koronavirus

Vaksen COVID-19: Kontra ant Komisyon Ewopeyen an ak Sanofi-GSK kounye a pibliye

SHARE:

pibliye

Depi 3 ane

on

Nou itilize enskripsyon ou pou bay kontni nan fason ou te konsanti ak amelyore konpreyansyon nou sou ou. Ou ka koupe abònman nan nenpòt ki lè.

On 9 February, the pharmaceutical company Sanofi-GSK has agreed to publish the redacted contract siyen with the Commission on 18 September 2020. The Commission welcomes the company's commitment towards more transparency in its participation in the roll-out of the EU Vaccines Strategy. Transparency and accountability are important to help build the trust of European citizens and to make sure that they can rely on the effectiveness and safety of the vaccines purchased at the EU level.

Jounal contract published contains redacted parts pertaining to confidential information. The Sanofi-GSK contract is the third one to be published, after CureVac ak AstraZeneca agreed to publish their Advance Purchase Agreement with the European Commission. The Commission is working with companies in view of publishing all contracts under the Advance Purchase Agreements in the near future.

Pataje atik sa a:

Sijè ki gen rapò:
EU Reporter pibliye atik ki soti nan yon varyete sous deyò ki eksprime yon pakèt pwen de vi. Pozisyon yo pran nan atik sa yo pa nesesèman sa yo nan EU Reporter.
reklam

Tendans